Compare Agilent Technologies Inc (A) vs VanEck Semiconductor ETF (SMH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs VanEck Semiconductor ETF — how do they compare? Agilent Technologies Inc trades at $128.5 (market cap $37.04B), while VanEck Semiconductor ETF trades at $591.32. The key difference: Agilent Technologies Inc pays a 0.78% dividend while VanEck Semiconductor ETF pays none, and VanEck Semiconductor ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | SMH | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $668.91 |
52-Week Low | $110.24 | $283.48 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
SMH trades at $581.45, down 1.83% amid a semiconductor sector sell-off. Technical indicators show a neutral bias with mixed moving averages and oscillators, while support and resistance levels suggest consolidation near $609 pivot. Recent news highlights chip stock volatility, with JPMorgan advising to buy the dip despite hedge fund outflows. The ETF remains a high-beta play on AI-driven semiconductor demand, though financial ratios are unavailable for valuation context.
Outlook hinges on AI capex cycles and memory chip shortages, but risks include sector rotation and earnings pressure. Institutional sentiment is cautious despite long-term growth themes, with technicals indicating near-term range-bound action. Investors face volatility from hyperscaler shifts and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About VanEck Semiconductor ETF
The fund normally invests at least 80% of its total assets in securities that comprise the target index. The index includes common stocks and depositary receipts of US exchange-listed companies in the semiconductor industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a US exchange. The fund is non-diversified.
Read more on SMH →
